Objective: To investigate the effect of a 36-ingredient micronutrient formula consisting mainly of minerals and vitamins in the treatment of adults with both ADHD and severe mood dysregulation (SMD). Method: 14 medication-free adults (9 men, 5 women; 18-55 years) with ADHD and SMD completed an 8-week open-label trial. Results: A minority reported transitory mild side effects. Significant improvements were noted across informants (self, observer, clinician) on measures of inattention and hyperactivity/impulsivity, mood, quality of life, anxiety, and stress all with medium to very large effect sizes (all ps < .01); however, the mean of inattention remained in a clinical range whereas the means on measures of mood and hyperactivity/impulsivity were normalized. Follow-up data showed maintenance of changes or further improvement for those who stayed on the micronutrients. Conclusions: Although this study, as an open trial, does not in itself prove efficacy, it provides preliminary evidence supporting the need for a randomized clinical trial of micronutrients as treatment for the more complex presentations of ADHD.
Akhondzadeh, S., Mohammadi, M.-R., & Khademi, M. ( 2004). Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial. BMC Psychiatry, 4, 9.
2.
Almeida Montes, L.G., Hernandez Garca, A.O., & Ricardo-Garcell, J. (2007). ADHD prevalence in adult outpatients with nonpsychotic psychiatric illnesses. Journal of Attention Disorders, 11, 150-156.
3.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
4.
Ames, B.N., Elson-Schwab, I., & Silver, E. ( 2002). High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): Relevance to genetic disease and polymorphisms. American Journal of Clinical Nutrition , 75, 616-658.
5.
Arnold, L.E. ( 1999). Treatment alternatives for attention-deficit/ hyperactivity disorder (ADHD). Journal of Attention Disorders, 3, 30-48.
6.
Arnold, L.E., Amato, A., Bozzolo, H., Hollway, J., Cook, A., Ramadan, Y., et al. (2007). Acetyl-l-carnitine in attention-deficit/hyperactivity disorder: A multi-site, placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology, 17, 791-801.
7.
Arnold, L.E., Bozzolo, H., Hollway, J., Cook, A., DiSilvestro, R.A., Bozzolo, D.R., et al. (2005). Serum zinc correlates with parent- and teacher-rated inattention in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology , 15, 628-636.
8.
Barkley, R.A. ( 1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121, 65-94.
9.
Barkley, R.A. ( 2001). The inattentive type of ADHD as a distinct disorder: What remains to be done. Clinical Psychology: Science and Practice, 8, 489-493.
10.
Baroni, A., Lunsford, J.R., Luckenbaugh, D.A., Towbin, K.E., & Leibenluft, E. (2009). Practitioner review: The assessment of bipolar disorder in children and adolescents. Journal of Child Psychology and Psychiatry, 50, 203-215.
11.
Baumgaertel, A. ( 1999). Alternative and controversial treatments for attention-deficit/hyperactivity disorder. Pediatric Clinics of North America, 46, 977-992.
12.
Biederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Harpold, T., et al. (2006). A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/ hyperactivity disorder . Biological Psychiatry, 59, 829-835.
13.
Bilici, M., Yildirim, F., Kandil, S., Bekaroglu, M., Yildirmis, S., Deger, O., et al. (2004). Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder . Progress in Neuro-Psychopharmacology and Biological Psychiatry , 28, 181-190.
14.
Cian, C., Koulmann, N., Barraud, P.A., Raphel, C., Jimenez, C., & Melin, B. ( 2000). Influences of variations in body hydration on cognitive function: Effect of hyperhydration, heat stress, and exercise-induced dehydration . Journal of Psychophysiology, 14, 29-36.
15.
Conners, C.K., Erhardt, D., & Sparrow, M.A. ( 2003). Conners’ Adult ADHD Rating Scales (CAARS). Archives of Clinical Neuropsychology, 18, 431-437.
16.
Costa e Silva, J. ( 1998). Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression. Journal of Clinical Psychiatry, 59, 352-357.
17.
Derefinko, K.J., Adams, Z.W., Milich, R., Fillmore, M.T., Lorch, E.P., & Lynam, D.R. ( 2008). Response style differences in the inattentive and combined subtypes of attention-deficit/hyperactivity disorder. Journal of Abnormal Child Psychology, 36, 745-758.
18.
Ekholm, P., Reinivuo, H., Mattila, P., Pakkala, H., Koponen, J., Happonen, A., et al. (2007). Changes in the mineral and trace element contents of cereals, fruits and vegetables in Finland. Journal of Food Composition and Analysis, 20, 487-495.
19.
Epstein, J., Johnson, D., & Conners, C. ( 2002). Conners’ adult ADHD diagnostic interview for DSM-IV (CAADID): Technical manual. New York: MHS.
20.
First, M.B., Spitzer, R.L., Gibbon, M., & Williams, J.B.W. (2002). Structured clinical interview for DSM-IV-TR axis i disorders, research version (Patient ed.). New York: Biometrics Research, New York State Psychiatric Institute.
21.
Frazier, E., Fristad, M.A., & Arnold, L.E. ( 2009). Multinutrient supplement as treatment: Literature review and case report of a 12-year-old boy with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 19, 453-460.
22.
Gately, D., & Kaplan, B.J. ( 2009). Database analysis of adults with bipolar disorder consuming a multinutrient formula. Clinical Medicine: Psychiatry, 4, 3-16.
23.
Gualtieri, C.L., Ondrusek, M.G., & Finley, C. ( 1985). Attention deficit disorders in adults. Clinical Neuropharmacology, 8, 343-356.
24.
Hawley, C.J., Gale, T.M., & Sivakumaran, T. (2002). Defining remission by cut off score on the MADRS: selecting the optimal value. Journal of Affective Disorders, 72, 177-184.
Kaplan, B.J., Crawford, S.G., Gardner, B., & Farrelly, G. ( 2002). Treatment of mood lability and explosive rage with minerals and vitamins: Two case studies in children. Journal of Child and Adolescent Psychopharmacology, 12, 205-219.
27.
Kaplan, B.J., Fisher, J.E., Crawford, S.G., Field, C.J., & Kolb, B. ( 2004). Improved mood and behavior during treatment with a mineral-vitamin supplement: an open-label case series of children. Journal of Child and Adolescent Psychopharmacology, 14, 115-122.
28.
Kaplan, B.J., Simpson, J.S.A., Ferre, R.C., Gorman, C.P., McMullen, D.M., & Crawford, S.G. (2001). Effective mood stabilization with a chelated mineral supplement: An open-label trial in bipolar disorder . Journal of Clinical Psychiatry, 62, 936-944.
29.
Kaptchuk, T.J., Kelley, J.M., Conboy, L.A., Davis, R.B., Kerr, C.E., Jacobson, E.E., et al. (2008). Components of placebo effect: Randomised controlled trial in patients with irritable bowel syndrome. British Medical Journal, 336, 999-1003.
30.
Kessler, R.C., Adler, L., Barkley, R., Biederman, J., Conners, C.K., Demler, O., et al. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the national comorbidity survey replication . American Journal of Psychiatry, 163, 716-723.
31.
Khan, A., Leventhal, R.M., Khan, S.R., & Brown, W.A. ( 2002). Severity of depression and response to antidepressants and placebo: An analysis of the food and drug administration database. Journal of Clinical Psychopharmacology, 22, 40-45.
32.
Kolar, D., Keller, A., Golfinopoulos, M., Cumyn, L., Syer, C., & Hechtman, L. ( 2008). Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment, 4, 389-403.
33.
Leon, A.C., Solomon, D.A., Mueller, T.I., Endicott, J., Posternak, M., Judd, L.L., et al. (2000). A brief assessment of psychosocial functioning of subjects with bipolar I disorder: The LIFE-RIFT. Longitudinal interval follow-up evaluation-range impaired functioning tool. Journal of Nervous and Mental Disease, 188, 805-812.
34.
Lovibond, S.H., & Lovibond, P.F. (1995). Manual for the Depression Anxiety Stress Scales (2nd ed.). Sydney: Psychology Foundation.
35.
Luty, S.E., Carter, J.D., McKenzie, J.M., Rae, A.M., Frampton, C.M.A., Mulder, R.T., et al. (2007). Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. British Journal of Psychiatry, 190, 496-502.
36.
Mattes, J.A., Boswell, L., & Oliver, H. ( 1984). Methylphenidate effects on symptoms of attention deficit disorder in adults. Archives of General Psychiatry, 41, 1059-1063.
37.
Mayer, A.B. ( 1997). Historical changes in the mineral content of fruits and vegetables. British Journal of Food, 99, 207-211.
38.
Medori, R., Ramos-Quiroga, J.A., Casas, M., Kooij, J.J.S., Niemela, A., Trott, G.-E., et al. (2008). A randomized, placebo-controlled trial of three fixed dosages of prolonged release OROS methylphenidate in adults with attention-deficit/ hyperactivity disorder. Biological Psychiatry, 63, 981-989.
39.
Mertz, W. ( 1994). A balanced approach to nutrition for health: The need for biologically essential minerals and vitamins. Journal of the American Dietetic Association, 94, 1259-1262.
40.
Montgomery, S.A., & Asberg, M. ( 1979). A new depression scale designed to be sensitive to change . British Journal of Psychiatry, 134, 382-389.
41.
Morishita, S., & Arita, S. ( 2005). Clinical characteristics as predictors of response to fluvoxamine, paroxetine and milnacipran in patients with depression. Current Psychiatry Reviews, 1, 319-324.
42.
Müller, M.J., Szegedi, A., Wetzel, H., & Benkert, O. ( 2000). Moderate and severe depression: Gradations for the MontgomeryÅsberg Depression Rating Scale. Journal of Affective Disorders, 60, 137-140.
43.
Nemeroff, C.B., & Thase, M.E. ( 2007). A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. Journal of Psychiatric Research, 41, 351-359.
44.
Nemzer, E.D., Arnold, L.E., Votolato, N.A., & McConnell, H. ( 1986). Amino acid supplementation as therapy for attention deficit disorder. Journal of the American Academy of Child Psychiatry , 25, 509-513.
45.
Nigg, J.T. ( 2000). On inhibition/disinhibition in developmental psychopathology: Views from cognitive and personality psychology and a working memory taxonomy . Psychological Bulletin, 126, 200-246.
46.
Nigg, J.T. ( 2001). Is ADHD a disinhibitory disorder? Psychological Bulletin, 127, 571-598.
47.
Novaco, R.W. ( 2003). The Novaco Anger Scale and Provocation Inventory (NAS-PI) . Los Angeles: Western Psychological Services.
48.
O’Driscoll, D.A., Depatie, L., Holahan, A.V., Savion-Lemieux, T., Barr, R.G., Jolicoeur, C., et al. (2005). Executive functions and methylphenidate response in subtypes of attention-deficit/ hyperactivity disorder. Biological Psychiatry, 57, 1452-1460.
49.
Oyesanmi, O., Kunkel, E.J.S., Monti, D.A., & Field, H.L. ( 1999). Hematologic side effects of psychotropics. Psychosomatics: Journal of Consultation Liaison Psychiatry, 40, 414-421.
50.
Polanczyk, G., de Lima, M.S., Horta, B.L., Biederman, J., & Rohde, L.A. ( 2007). The worldwide prevalence of ADHD: A systematic review and meta-regression analysis. American Journal of Psychiatry , 164, 942-948.
51.
Popper, C.W. ( 2001). Do vitamins or minerals (apart from lithium) have mood-stabilising effects? Journal of Clinical Psychiatry, 62, 933-935.
52.
Reimherr, F.W., Marchant, B.K., Strong, R.E., Hedges, D.W., Adler, L., Spencer, T.J., et al. (2005). Emotional dysregulation in adult ADHD and response to atomoxetine. Biological Psychiatry, 58, 125-131.
53.
Reimherr, F.W., Wender, P.H., Wood, D.R., & Ward, M. ( 1987). An open trial of {l}-tyrosine in the treatment of attention deficit disorder, residual type. American Journal of Psychiatry , 144, 1071-1073.
54.
Rowe, D.C., Stever, C., & Gard, J.M.C. ( 1998). The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behavior Genetics, 28, 215-225.
55.
Rucklidge, J.J. ( 2009). Successful treatment of OCD with a micronutrient supplement following partial response to Cognitive Behavioral Therapy (CBT): A case study . Journal of Anxiety Disorders, 23, 836-840.
56.
Rucklidge, J.J., Johnstone, J., & Kaplan, B.J. ( 2009). Nutrient supplementation approaches in the treatment of ADHD. Expert Review of Neurotherapeutics, 9, 461-476.
57.
Rucklidge, J.J., & Kaplan, B.J. ( 1997). Psychological functioning of women identified in adulthood with attention-deficit/ hyperactivity disorder. Journal of Attention Disorders, 2, 167-176.
58.
Russell, V.A., Oades, R.D., Tannock, R., Killeen, P.R., Auerbach, J.G., Johansen, E.B., et al. (2006). Response variability in attention-deficit/hyperactivity disorder: A neuronal and glial energetics hypothesis. Behavioral and Brain Function, 2, 23.
59.
Sagvolden, T., Aase, H., Johansen, E.B., & Russell, V.A. ( 2005). A dynamic developmental theory of attention-deficit/ hyperactivity disorder (ADHD) predominantly hyperactive/ impulsive and combined subtypes. Behavioral and Brain Sciences, 28, 397-468.
60.
Scheen, A.J., & De Hert, M.A. (2007). Abnormal glucose metabolism in patients with antipsychotics. Diabetes and Metabolism, 33, 169-175.
61.
Simmons, M. ( 2003). Nutritional approach to bipolar disorder. Journal of Clinical Psychiatry, 64, 338-338.
62.
Skirrow, C., McLoughlin, G., Kuntsi, J., & Asherson, P. ( 2009). Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability. Expert Review of Neurotherapeutics, 9, 489-503.
63.
Spearing, M.K., Post, R.M., Leverich, G.S., Brandt, D., & Nolen, W. ( 1997). Modification of the clinical global impressions (CGI) scale for use with bipolar illness (BP): The CGI: BP. Psychiatry Research, 73, 159-171.
64.
Spencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., et al. (2005). A Large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 57, 456-463.
65.
Starobrat-Hermelin, B. ( 1998). The effect of deficiency of selected bio-elements on hyperactivity in children with certain specified mental disorders. Annales Academiae Medicae Stetinensis, 44, 297-314.
66.
Starobrat-Hermelin, B., & Kozielec, T. ( 1997). The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnesium Research, 10, 149-156.
67.
Thomson, C.D., & Robinson, M.F. (1980). Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand. The American Journal of Clinical Nutrition, 33, 303-323.
68.
Torgersen, T., Bjervan, B., & Rasmussen, K. ( 2008). Treatment of adult ADHD: Is current knowledge useful for clinicians? Neuropsychiatric Disease and Treatment, 4, 177-186.
69.
Umphress, V.J., Lambert, M.J., Smart, D.W., Barlow, S.H., & Clouse, G. ( 1997). Concurrent and construct validity of the outcome questionnaire . Journal of Psychoeducational Assessment, 15, 40-55.
70.
Van Oudheusden, L.J., & Scholte, H.R. ( 2002). Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 67, 33-38.
71.
Wampold, B.E., Imel, Z.E., & Minami, T. ( 2007). The placebo effect: "Relatively large" and "robust" enough to survive another assault. Journal of Clinical Psychology , 63, 401-403.
Wynne, A., McCartney, A., Brostoff, J., Hudspith, B., & Gibson, G. ( 2004). An in vitro assessment of the effects of broad-spectrum antibiotics on the human gut microflora and concomitant isolation of a Lactobacillus plantarum with anti-Candida activities. Anaerobe, 10, 165-169.
74.
Young, L.T. ( 2007). Is bipolar disorder a mitochondrial disease? Journal of Psychiatry and Neuroscience, 32, 160-161.
75.
Young, R.C., Biggs, J.T., Ziegler, V.E., & Meyer, D.A. ( 1978). A rating scale for mania: Reliability, validity, and sensitivity. British Journal of Psychiatry, 133, 429-435.
76.
Zhang, Z.-J., Tan, Q.-R., Tong, Y., Li, Q., Kang, W.-H., Zhen, X.-C., et al. (2008). The effectiveness of carbamazepine in unipolar depression: A double-blind, randomized, placebo-controlled study. Journal of Affective Disorders, 109, 91-97.
